LFG
GMAB icon

Larson Financial Group’s Genmab GMAB Stock Holding History

Larson Financial Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.95K Sell
110
-112
-50% -$3.36K ﹤0.01% 2840
2025
Q4 		$6.84K Buy
222
+194
+693% +$6.05K ﹤0.01% 2326
2025
Q3 		$859 Buy
+28
New +$682 ﹤0.01% 2962
2023
Q4 		– Sell
-31
Closed -$1.09K – 1845
2023
Q3 		$1.09K Buy
+31
New +$1.18K ﹤0.01% 1474

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Larson Financial Group's GMAB Position: Q1 2026 in Review

Larson Financial Group reduced its Genmab (GMAB) stake by 50% in Q1 2026, selling an estimated $3.36K and leaving 110 shares worth $2.95K. The position accounts for ﹤0.01% of the portfolio, ranked #2840.

Larson Financial Group first reported a position in GMAB in Q3 2023 and has held it in 4 quarters since. The position peaked at $6.84K in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Larson Financial Group held 110 shares of Genmab worth $2.95K as of Q1 2026.
  • Larson Financial Group sold 112 Genmab shares in Q1 2026, an estimated $3.36K.
  • Genmab made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2840 holding.
  • Larson Financial Group first reported a position in Genmab in Q3 2023 and has held it in 4 quarters since.
  • Larson Financial Group's Genmab position peaked at $6.84K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.